AB050. Later onset Fabry disease, cardiac damage progress in silence-experience with a highly prevalent mutation

Documenti analoghi

• AB018. Revisited later-onset cardiac type Fabry disease—cardiac damages progressed in silence—experiences from an extremely high prevalent area, Taiwan
  di: Niu, Dau-Ming, et al.
  Pubblicazione: (2015)
• AB077. Identification of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulation in endomyocardial biopsies before the occurrence of typical pathological changes of Fabry disease
  di: Niu, Dau-Ming, et al.
  Pubblicazione: (2017)
• A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutation
  di: Lee, Han-Jui, et al.
  Pubblicazione: (2017)
• Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset fabry mutation (IVS4 + 919G > A)
  di: Hsu, Ting-Rong, et al.
  Pubblicazione: (2014)
• High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening
  di: Spada, Marco, et al.
  Pubblicazione: (2006)